BioMarin's Morquio A drug confers "modest" benefit: FDA review
(Reuters) - An experimental drug to treat a rare genetic disorder that causes skeletal malformation and a host of related lung, eye ear and heart prob...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/dN7r8fPjiPc/story01.htm
No comments:
Post a Comment